Table 6.
Studies reported peptide-based vaccine candidate
| Author | Target | Suggested candidates |
|---|---|---|
| Abdelmageed et al. | Envelope protein as an immunogenic target | T-cell epitope-based candidate[11] |
| Kalita et al. | Multiple targets | Multi-epitope-based subunit vaccine showing good protective efficacy and safety in humans[28] |
| Herst et al. | CD8+T-cell immunity | Adjuvanted microsphere peptide vaccine formulation containing NP44-52 confers immunity in mice[29] |
| Kharisma and Ansori | BCR/Fab molecular complexes | Pep_4 ADHQPQTFVNTELH as an epitope-based peptide vaccine It has a high level of immunogenicity[30] |
| Jakhar et al. | TLR-3 | Selection of conformational B-cell epitopes and docking studies Designed multi-epitope peptide vaccine[31] |
BCR=B-cell receptor, TLR=Toll-like receptor